Products for Research Use Only
RegisterLogin

BMS-927711 10mg

CAT: 0628-A13102-10Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0628-A13102-10Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1289023-67-1

Chemical Information

Rimegepant

Rimegepant is an oral antagonist of the CGRP receptor developed by Biohaven Pharmaceuticals. It received FDA approval on February 27, 2020 for the acute treatment migraine headache, and was subsequently approved by the European Commission in April 2022 for both the treatment and prevention of migraines. While several parenteral antagonists of CGRP and its receptor have been approved for migraine therapy (e.g. [erenumab], [fremanezumab], [galcanezumab]), rimegepant and [ubrogepant] were the only CGRP antagonists that possessed oral bioavailability until the approval of [atogepant] in 2021. The current standard of migraine therapy involves abortive treatment with "triptans", such as [sumatriptan], but these medications are contraindicated in patients with pre-existing cerebrovascular and cardiovascular disease due to their vasoconstrictive properties. Antagonism of the CGRP pathway has become an attractive target for migraine therapy as, unlike the triptans, oral CGRP antagonists have no observed vasoconstrictive properties and are therefore safer for use in patients with contraindications to standard therapy.

CAS Number1289023-67-1
PubChem CID51049968
IUPAC Name[(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate
Molecular FormulaC28H28F2N6O3
Molecular Weight534.6
XLogP2.3
Topological Polar Surface Area114
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Heavy Atom Count39
Formal Charge0
Complexity891
SMILES
C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6
InChI
InChI=1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/t18-,22+,24-/m0/s1
InChIKey
KRNAOFGYEFKHPB-ANJVHQHFSA-N
Chemical Structure
2D Structure
2D structure of Rimegepant
CAS: 1289023-67-1
CID: 51049968
Formula: C28H28F2N6O3
MW: 534.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight534.6
XLogP32.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass534.21909510
Monoisotopic Mass534.21909510
Topological Polar Surface Area114 Ų
Heavy Atom Count39
Formal Charge0
Complexity891
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
A13102-1BMS-927711 1mg
A13102-50BMS-927711 50mg
A13102-5BMS-927711 5mg
A13102-100BMS-927711 100mg
A13102-25BMS-927711 25mg
A13102-10mM-DBMS-927711 10mM * 1mL in DMSO
A17040-10BMS-813160 10mg
A17013-10BMS-986205 10mg
A12839-10BMS-5 10mg
A11319-10BMS-509744 10mg

Alternative Products

CatalogName
A3259-2BMS-927711
C12100-1gRimegepant (BMS-927711)
MBS386661-01BMS-806 (BMS 378806)
BA9174-50BMS-564929
BA5455-5BMS-986278
BA5193-5BMS-986224

Popular Products